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Abstract
Thyroid hormone (TH) is critical to normal brain development, but the mechanisms operating in this process are poorly
understood. We used chromatin immunoprecipitation to enrich regions of DNA bound to thyroid receptor beta (TRb)o f
mouse cerebellum sampled on post natal day 15. Enriched target was hybridized to promoter microarrays (ChIP-on-chip)
spanning 28k bt o+2 kb of the transcription start site (TSS) of 5000 genes. We identified 91 genes with TR binding sites.
Roughly half of the sites were located in introns, while 30% were located within 1 kb upstream (59) of the TSS. Of these
genes, 83 with known function included genes involved in apoptosis, neurodevelopment, metabolism and signal
transduction. Two genes, MBP and CD44, are known to contain TREs, providing validation of the system. This is the first
report of TR binding for 81 of these genes. ChIP-on-chip results were confirmed for 10 of the 13 binding fragments using
ChIP-PCR. The expression of 4 novel TH target genes was found to be correlated with TH levels in hyper/hypothyroid
animals providing further support for TR binding. A TRb binding site upstream of the coding region of myelin associated
glycoprotein was demonstrated to be TH-responsive using a luciferase expression system. Motif searches did not identify
any classic binding elements, indicating that not all TR binding sites conform to variations of the classic form. These findings
provide mechanistic insight into impaired neurodevelopment resulting from TH deficiency and a rich bioinformatics
resource for developing a better understanding of TR binding.
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Introduction
Thyroid hormone (TH) is essential for brain development in
humans and animals [1]. The neonatal period of human
development is particularly well-studied in part because of the
disorder known as congenital hypothyroidism (CH) [2]. CH occurs
at a rate of approximately 1 in 3,500 live births [3], though this
may be increasing [4]. CH infants do not present early specific
clinical features; therefore, only 10% of CH infants were
diagnosed within the first month, 35% within 3 months, 70%
within the first year, and 100% only after age 3 [5,6] before
neonatal screening for TH was implemented. The intellectual
deficits resulting from this delayed diagnosis and treatment were
profound. One meta-analysis found that the mean full-scale
intelligence quotient (IQ) of 651 CH infants was 76 [7]. Moreover,
the percentage of CH infants with an IQ above 85 was 78% when
the diagnosis was made within 3 months of birth, 19% when it was
made between 3 and 6 months, and 0% when diagnosed after 7
months of age [7,8]. Thus, TH plays a major role in brain
development and thyroid dysfunction is a major cause of mental
retardation. This is also particularly important because a large
number of environmental contaminants may impact thyroid
function and/or thyroid hormone action [9–12].
The molecular mechanisms by which TH impacts brain
development are becoming better understood. In general, it is
postulated that many of the effects of TH are mediated by their
receptors (TRs) – nuclear proteins that directly regulate gene
expression [13]. Likewise, the neurodevelopmental events affected
by TH are also becoming better understood. For example, TH
appears to regulate fate specification of early cortical neurons [14],
migration of cortical [15] and cerebellar [16] neurons, synapto-
genesis[17,18] and apoptosis [19,20]. However, the specific genes
that are directly regulated by TH through the TRs, and which
account for TH effects on specific developmental events, are
poorly characterized. Moreover, we know little about the DNA
regulatory elements through which TRs exert their actions on
gene regulation [21].
Identification of direct targets of TH in the developing brain has
proven difficult, but perhaps for predictable reasons. Specifically,
we [19,22] and others [23,24] have attempted to identify TH-
responsive genes in the developing brain using a variety of
‘‘functional genomics’’ approaches. All of these reports employed
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weakness in this approach is that the cellular phenotype of the
hypothyroid brain in development is significantly different from
that of the euthyroid brain. For example, the hypothyroid brain
has considerably more astrocytes and fewer oligodendrocytes in
areas of white matter [25,26]. Therefore, it is likely that a large
number of expressed sequences that differ in abundance when
thyroid hormone levels are manipulated during development
reflect differences in cellular phenotype at the time of sacrifice.
Considering the importance of TH to brain development and
the challenge of identifying direct gene targets of TH action, we
reasoned that chromatin immunoprecipitation combined with
DNA microarray analysis (ChIP-on-chip) would be an effective
approach to identify direct gene targets of TH. Moreover, we
chose to focus on the neonatal (postnatal day (PND) 15)
cerebellum because it is a well studied target of TH action in
development [27]. Circulating TH levels reach a peak at PND 15
[28,29], the critical time point marked by the onset of active
myelination and synapses refinement in Purkinje cells [25,30,31].
We employed custom DNA microarrays that contained probes
covering 10 kb of genomic sequences flanking the transcription
start site (TSS) of 5000 genes selected from our pervious
microarray studies and related literatures. The use of microarrays
containing selected genes tends to limit the potential for false
positives that would invariably occur with arrays containing the
entire genome and increases the number of probes per gene, thus
improving sensitivity and resolution. This study represents the first
large-scale approach to identify direct gene targets of TH action in
the developing brain.
Results
Assessing specificity of polyclonal antibody and ChIP
protocol
The TRb-1 antibody used for ChIP in the current study showed
high specificity as indicated by Western blot analysis using GH3
cell extracts (Figure 1 A). A single band of 52 kDa was detected as
expected. Immunoprecipitated (IP) DNA and total input (TI)
DNA were amplified and evaluated by confirming the enrichment
of the well-characterized TRE in the promoter of myelin basic
protein (MBP) [32] by PCR before samples were hybridized to
DNA microarrays. Figure 1 B shows clear enrichment of MBP-
Figure 1. Assessing specificity of antibody and ChIP protocol. A. Characterization of TRb antibody with the GH3 cell line. A single 52 kDa
band was detected with Western blot. B. Characterization of the enrichment of MBP-TRE in all cerebellum samples. Enrichment of fragments from the
promoter region of b-actin and MBP was examined with PCR using IP and TI DNA amplified with WGA kit. One representative sample in the bottom
shows the enrichment in non-amplified DNA. The right panel shows the enrichment ratio of MBP to b-actin calculated using quantified band
intensities.
doi:10.1371/journal.pone.0004610.g001
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of male mice at PND 15.
Identification of TRb binding sites
Five cerebella of male mice, shown in Figure 1 B, were analysed
using the Agilent custom promoter arrays that contained probes
covering 10 kb of genomic sequences flanking the TSS of 5000
selected genes. Complete microarray data are available at
MIAMExpress (http://www.ebi.ac.uk/miamexpress/cgi-bin/mx.
cgi; accession number E-MEXP-1801). The genes identified with
the Chip Analytics software as enriched in at least 3 samples are
listed in Table 1, along with the genomic location of the binding
sites, enrichment log ratio, and general biological function. As
shown in Figure 2, approximately half of the binding sites were
located in introns, while about 30% of them were located within
1 kb upstream (59) of the TSS of their associated gene. Figure 3
shows examples of ChIP enrichment data for 4 representative
genes. The plots show enrichment ratios along with chromosomal
positions (NCBI build 34) in the mouse genome. Arrows indicate
both the TSS and direction of transcription.
Validation of the binding sites with ChIP-PCR
In order to verify the robustness of binding sites found with
ChIP-on-chip, we randomly selected and analyzed 13 binding sites
for confirmation of their enrichment using PCR. b-actin was used
as a negative control, and MBP-TRE was used as a positive
control. Amplified TRb-IP or IgG-IP DNAs along with TI-DNAs
from 2 cerebella were pooled, with equal quantities of DNA from
each sample, and used as template for PCR. Ten of the 13 genes
were confirmed to be enriched with TRb binding as shown in
Figure 4. Of the 10 confirmed genes, CD44 and VLDLR have
previously been reported as TH responsive genes [29,30]. In
addition to the well-known TRE sequence in the promoter region
of MBP, we also identified a second enrichment site in the first
intron of Golli-MBP [31]. As 3 (Fign, CD81and Pax3) of 13
binding sites tested were not confirmed by PCR, these data suggest
the analysis has false discovery rate of approximately 23% (3/13).
Expression of novel TH target genes in TH modulated
animal models
Among the 10 ChIP-PCR validated genes, SMS (Spermine
Synthase), LMO2 (Lim domain only 2) and GTF3c1 (General
Transcript Factor 3c1) were selected for further assessment of TH
regulation using in vivo models; this selection was based on the
paucity of literature regarding TH control of their expression. In
addition, myelin associated glycoprotein (MAG) was also selected
for further analysis as it has been shown to be altered by TH status
butnoTREhasbeendescribed forthisgene [32].Theexpression of
MBP was, again, used as a positive control for TH-induced gene
regulation in the various animal models. Serum T4 levels in 6-
propyl thiouracil (PTU) -or mercapto-methylimidazole (MMI)/
perchlorate-treated pups were significantly reduced while TH
injected pups were shown to have significantly elevated serum TH
levels compared with control pups. The serum T4 levels in TH
replacement pups rendered hypothyroid by MMI/perchlorate were
approximately equivalent to control levels (Table S1). The
expression of MBP varied with TH level (Figure 5 A and B).
Similar to MBP, the expression of SMS, MAG and LMO2 were
significantly changed corresponding with the TH levels. A
significant change in expression of GTF3c1 was not found in TH
injected pups or those rendered hypothyroid with MMI/perchlo-
ratetreatment,butexpressionwaselevatedalmost 2fold(p,0.05)in
cerebella of hypothyroid/replacement group and reduced to almost
0.75 fold (p,0.05) in PTU-treated pups. The discrepancy in gene
expression in these two models may be explained by the different
mechanism through which these compounds act to induce
hypothyroidism. PTU inhibits TH synthesis by inhibition of
thyroperoxidase (TPO) and decreasing the activity of deiodinases,
while MMI/perchlorate acts by blocking iodine transportation and
enhancing hepatic catabolism [33].
Characterization of TRb binding region in promoter of
MAG
As described above, the TRb binding site in the promoter
region of MAG was confirmed with both ChIP-on-Chip and
ChIP-PCR. There were no obvious candidate TREs, based on the
degenerate consensus sequence, across this binding region. To
further characterize the TRE sequence in this region, we
constructed a series of truncated MAG-promoter reporter
plasmids (shown in Figure 6 A). The reporter system was validated
by examining the effect of T3 treatment on transcriptional activity
of the Growth Hormone (GH) TRE sequence cloned into the
reporter vector. T3 induced GH transcriptional activity by 1.6-fold
(Figure 6 B). T3 also increased transcriptional activity of a MAG-
promoter reporter plasmid 3 containing a fragment from 2390 bp
to the TSS, by 1.4-fold. Deletion of the 110 bp fragment from
2390 to 2280 bp resulted in a decrease in the basal transcription
level; transcription activity was induced by only 1.2 fold with T3
treatment (Figure 6 C). These results indicate that the binding site
spanning a region of 110 bp (2390 to 2280) may include the
potential TREs.
Discussion
This is the first report of a relatively large-scale approach to
identify direct TH gene targets in the developing mouse brain.
Using ChIP-on-chip approach, we identified TRb binding
fragments corresponding to 91 genes in the cerebellum of male
mice at PND 15. Approximately half of these sites are located
within introns, and 30% are located within 1 kb upstream of the
TSS. Several of these genes are known direct targets of TH action
(CD44, MBP and VLDLR), indicating that our strategy was
capable of identifying known targets. In addition to confirming the
classical TRE in the MBP promoter [34], we identified a novel TR
binding site well upstream of the classic MBP TSS, located within
the first intron of an alternate transcript of this gene known as
Golli MBP [35]. Golli-MBP is expressed not only in myelin-
forming cells, but also in neurons in the CNS and peripheral
nervous system, and in macrophage and T-cells of the immune
system [36,37]. Direct TR regulation of Golli-MBP indicates the
important role of TH in myelination and migration of oligoden-
drocytes, in addition to its role in the immune system. These
findings provide a first glimpse at the specific gene targets through
which TH controls cerebellar histogenesis in the mouse.
We found that a large proportion (47%) of the TR binding sites
are located within introns, suggesting that transcriptional control
by TR could be exerted at sites downstream of the TSS. It has
long been recognized that active TREs can reside within introns of
TH responsive genes. The TH-regulated expression of GH is
mediated through both a TRE in the regulatory region upstream
of the TSS [38] and a site with higher affinity for TR within the
third intron of the gene [39]. Similarly, the expression of hepatic
carnitine palmitoyltransferase-I alpha, an enzyme involved in fatty
acid metabolism, is regulated by TR action at a TRE located in
the first intron [40]. Intronic locations of transcriptional regulatory
sites appear to be common for a variety of nuclear receptors
including the androgen receptor [41], glucocorticoid receptor
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Acc. No. Gene Symbol Probe Location Enrichment Log ratio Median
Rep1 Rep2 Rep3 Rep4 Rep5
Apoptosis
NM_028133 Egln3 intron 2.7 1.59 1.77 2.28 1.63 1.77
NM_178931 Tnfrsf14 intron 1.92 1.8 2.45 2.01 1.36 1.92
NM_010589 Jak3 2.2 kb 59 4.32 3.22 1.7 2.02 1.32 2.02
NM_008353 Il12rb1 6.7 kb 59 2.88 1.93 2.17 2.1 1.76 2.1
NM_007466 Api5 intron 2.88 4.52 0.29 2.27 0.74 2.27
NM_175445 Rassf2 0.7 kb 59 1.58 2.57 2.76 2.46 2.2 2.46
NM_013929 Siva 0.7 kb 59 2.24 2.7 2.52 3.06 2.91 2.7
NM_008841 Pik3r2 intron 5.28 3.15 1.78 2.92 1.85 2.92
NM_009746 Bcl7c intron 2.39 3.1 4.56 5.1 1.28 3.1
NM_022654 Lrdd 0.6 kb 39 6.85 3.83 6.48 3.09 4.95 4.95
Cell cycle
NM_133655 Cd81 intron 1.56 1.33 2.2 1.87 1.37 1.56
NM_023117 Cdc25b 0.1 kb 59 1.44 3.03 1.73 1.7 1.96 1.73
NM_030241 Setd8 0.2 kb 59 2.53 4.06 1.44 1.89 1.12 1.89
Teeth or bone development
BC005460 Ncl 0.4 kb 59 1.95 1.98 1.38 1.26 1.78 1.78
NM_010514 Igf2 intron 3.46 2.83 1.39 1.91 1.53 1.91
NM_008275 Hoxd13 1.2 kb 59 2.26 2.73 2.3 6.33 2.42 2.42
NM_145925 Pttg1ip intron 3.66 3.14 3.39 3.93 0.87 3.39
RNA or DNA process
AK077829 Rad51ap1 intron 5.02 2.34 4.68 2.72 2.48 2.72
AK077107 Frg1 0.2 kb 59 1.92 1.48 3.5 2.56 1.69 1.92
NM_182650 Hnrnpa2b1 0.5 kb 59 3.13 4.89 5.08 1.66 2.03 3.13
Metabolism
NM_007823 Cyp4b1 intron 1.35 2.02 1.51 2 1.67 1.67
NM_011977 Slc27a1 intron 2.45 2.19 0.99 1.67 1.54 1.67
NM_025578 Mrps25 0.2 kb 59 3.64 1.74 2.86 1.37 1.75 1.75
NM_153803 Glb1l2 intron 7.42 1.29 4.57 1.93 0.86 1.93
NM_027868 Slc41a3 intron 2.08 2.19 2.54 2.07 1.66 2.08
NM_008131 Glul intron 1.85 2.67 2.14 2.14 2.11 2.14
NM_175311 Zfp513 intron 2.14 1.95 1.85 3.13 2.57 2.14
NM_010361 Gstt2 3.4 kb 59 1.73 4.32 1.71 2.44 2.31 2.31
NM_026796 Smyd2 intron 2.06 7.09 2.4 2.79 1.29 2.4
NM_011376 Sim1 1.5 kb 59 1.9 1.51 5.08 3.44 2.45 2.45
NM_025802 Pnpla2 intron 5.57 3.97 2.47 2.28 1.06 2.47
NM_008972 Ptma intron 2.89 3.74 2.47 2.26 2.02 2.47
NM_146188 Kctd15 0.8 kb 59 3.13 3.78 2.54 2.18 1.77 2.54
NM_008673 Nat1 6.2 kb 59 2.55 3.51 2.65 1.9 1.53 2.55
NM_020013 Fgf21 intron 2.09 2.56 5.73 2.78 2.37 2.56
NM_023122 Gpm6b intron 5.29 4.33 2.8 1.1 2.77 2.8
NM_019652 ASNA1 intron 4.7 5.65 2.84 2.3 2.41 2.84
NM_011506 Sucla2 intron 4.45 2.93 5.47 2.52 1.56 2.93
NM_025286 Slc31a2 intron 3.29 2.87 1.93 4.71 3.66 3.29
NM_011969 Psma7 intron 2.84 3.45 3.3 3.27 3.38 3.3
NM_007945 Eps8 0.6 kb 59 2.82 3.95 4.55 2.75 4.55 3.95
Nerve development
NM_027180 Centd2 3.8 kb 59 3.98 1.9 1.3 1.58 0.86 1.58
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Rep1 Rep2 Rep3 Rep4 Rep5
NM_010419 Hes5 7.8 kb 59 1.57 1.68 2.17 1.77 1.82 1.77
NM_008500 Lhx6 0.1 kb 59 5.12 5.26 1.83 1.82 1.26 1.83
NM_008630 Mt2 0.8 kb 59 1.85 2.85 1.99 1.4 0.85 1.85
NM_009851 CD44 intron 1.91 2.1 1.73 2.08 1.92 1.92
AF113001 Ncor2 0.7 kb 59 1.34 3.35 4.19 1.92 1.54 1.92
NM_207682 Kif1b 0.5 kb 59 1.16 1.96 2.89 3.4 1.17 1.96
NM_010758 Mag 0.4 kb 59 1.63 1.86 2 2.64 2.41 2
NM_001029873 Unc13a 4.5 kb 59 4.32 3.22 1.7 2.02 1.32 2.02
NM_021716 Fign 0.8 kb 59 1.81 2.08 2.32 3.55 1.6 2.08
NM_010777 Mbp intron 2.21 1.92 2.17 2.13 1.67 2.13
NM_010710 Lhx2 0.6 kb 59 3.29 2.52 2.17 2.1 1.28 2.17
NM_009800 Car11 0.2 kb 39 1.27 2.18 5.11 3.25 1.5 2.18
NM_009849 Entpd2 intron 2.19 2.18 3.25 2.92 1.84 2.19
NM_001025245 Mbp (Goli) intron 1.31 3.68 3.34 2.19 1.17 2.19
NM_009501 Vax1 1.4 kb 59 3.57 2.3 1.79 2.91 1.62 2.3
NM_009718 Neurog2 6.6 kb 59 3.16 2.42 2.32 1.87 1.58 2.32
NM_019446 BarhL1 0.9 kb 59 2.71 2.53 1.97 2.35 2.06 2.35
NM_008505 Lmo2 intron 2.04 2.43 2.38 2.65 2.04 2.38
NM_175750 Plxna4 2.8 kb 59 4.07 2.93 5.27 2.12 1.91 2.93
NM_013703 Vldlr intron 2.28 4.16 4.53 3.24 2.3 3.24
NM_201618 Gnas intron 3.51 3.63 3.78 4.64 2.18 3.63
NM_010700 Ldlr intron 2.61 4.31 3.51 3.73 4.62 3.73
NM_009214 Sms 1.0 kb 59 2.06 2.34 4.41 2.45 1.86 2.34
Signal transduction
NM_010098 Opn3 intron 2.13 2.78 2.67 2.25 1.97 2.25
NM_008772 P2ry1 intron 1.32 3.29 3.83 2.46 1.11 2.46
NM_183408 Pde4a intron 2.56 3.38 2.52 2.14 2.02 2.52
NM_011951 Mapk14 0.1 kb 59 2.94 2.12 6.09 4.14 1.55 2.94
NM_028041 DDX54 0.1 kb 59 3.2 3.92 1.94 3.4 2.02 3.2
NM_025569 Mgst3 0.2 kb 59 3.38 5.04 3.28 2.46 2.35 3.28
NM_009633 Adra2b 0.6 kb 59 1.86 3.51 6.38 3.72 0.9 3.51
NM_011305 Rxra 0.8 kb 59 1.37 1.67 1.93 1.42 1.71 1.67
NM_207239 Gtf3c1 intron 2.05 2.08 2.56 2.06 2.18 2.08
NM_016974 Dbp 0.5 kb 59 1.27 2.18 5.11 3.25 1.5 2.18
NM_178622 Suds3 4.7 kb 59 1.81 2.43 6.34 3.15 1.3 2.43
NM_172913 Tox3/Tnrc9 2.8 kb 59 2.66 3.95 1.72 3.63 1.94 2.66
NM_008781 PAX3 7.2 kb 59 3.17 4.13 1.76 2.88 1.67 2.88
NM_007624 Cbx3 0.3 kb 59 3.13 4.89 5.08 1.66 2.03 3.13
NM_010827 Msc 0.3 kb 59 3.88 2.63 2.66 41.3 3.38 3.38
NM_008093 Gata5 intron 3.89 3.66 5.23 1.91 2.11 3.66
NM_026646 Slc25a22 0.3 kb 59 6.85 3.83 6.48 3.09 4.95 4.95
Sperm function
NM_018808 DNAjb1 intron 1.69 2.12 3.91 1.94 1.21 1.94
NM_153144 Ggnbp2 intron 1.28 2.1 3.33 2.22 1.69 2.1
Unknown
NM_182930 Plekha6 7.4 kb 59 2.35 2.53 1.77 1.29 1.32 1.77
NM_028596 Riken intron 2.23 2.03 1.87 1.71 1.45 1.87
NM_198628 GM711 intron 1.28 1.88 5.24 1.88 0.99 1.88
Table 1. cont.
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BC085130 MKIAA4027 intron 4.26 2.01 2.16 1.57 0.63 2.01
NM_028696 Obfc2a intron 4.03 2.44 2.3 2.37 1.8 2.37
NM_026626 Efcab2 intron 2.31 3.2 3.98 2.49 1.88 2.49
NM_001101503 Riken 1.5 kb 39 2.93 3.14 2.69 3.93 1.59 2.93
NM_144558 BIVM 0.8 kb 59 1.65 2.03 3.07 3.12 3.74 3.07
doi:10.1371/journal.pone.0004610.t001
Table 1. cont.
Figure 2. Distribution of genomic locations of binding sites of 91 genes. The mid point of each probe was used to calculate the distance to
the closest gene.
doi:10.1371/journal.pone.0004610.g002
Figure 3. Examples of TRb binding activities identified with ChIP-on-chip. The plots show enrichment ratios for all probes within a genomic
region (IP versus TI DNA). Chromosomal positions are from NCBI build 34 of the mouse genome. The start and direction of transcription are noted by
arrows. Black bars on the X axis indicate the fragments whose enrichment was confirmed with PCR.
doi:10.1371/journal.pone.0004610.g003
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38 and 47% of estrogen receptor binding sites are located within
introns [45,46].
TR binding sites identified with ChIP-on-chip were analyzed
independently with ChIP-PCR for 13 randomly selected genes.
Ten of these sites were confirmed as enriched by TRb ChIP,
suggesting a false positive rate of approximately 23% for our
approach. ChIP-on-chip is a novel method to study chromatin –
DNA interactions over the entire genome. Our results are not
unusual given that previous data from ChIP-on-chip studies have
reported false positive rates as high as 30% [47]. There are a
number of confounding variables, including purity of ChIP DNA,
amplification methods and resolution of probes for each gene. It is
also probable that the list of enriched genes identified by ChIP-on-
chip is highly dependent on the algorithm applied (normalization,
statistics to identify enriched regions, criteria for calling a site
significant, etc.) which may influence the rate of false positives and
false negatives.
Identified as one of novel targets of TH regulation, SMS is
essential for transforming spermidine to spermine, which are
ubiquitous cellular components that play critical roles in cellular
physiology [48]. Polyamines are required for numerous cellular
processes including transcription, translation and modulation of
ion channel activities[49,50] Deficiency of SMS in mice is
associated with deafness, inner ear abnormalities, and hyperactiv-
ity, while congenital deficiency in humans is associated with
mental retardation and cerebellar abnormalities [51]. All of these
phenotypes are common manifestations of developmental hypo-
thyroidism [52]. In the current study we identified TR binding
sites in the promoter region of SMS. Moreover, TH positively
regulated the expression of SMS in both mouse models of TH
disruption. Microarray analyses of cerebellum transcript levels in
mice or rats treated with a low concentration of PTU showed that
SMS expression was reduced in hypothyroid mice of both sexes,
but only in male hypothyroid rats (in preparation). Therefore,
down-regulation of SMS, causing decreased production of
polyamines, may be one mechanism that leads to neurodevelop-
mental aberrations in the offspring of hypothyroid dams. More
work is required to investigate this pathway and its response to TH
in the brain.
Among the other novel TH target genes selected for further
analysis, LMO2 is a member of a family of genes encoding Lim-
only proteins, which are speculated to affect the development of
the mouse CNS because of their high expression in this region
[53–55]. Using both ChIP-on-chip and ChIP-PCR, we found that
TR bound to a LMO2 intron, and our results suggest that LMO2
expression is regulated by TH in our animal models. GTF3c1 is a
transcription factor required for the regulation of genes tran-
scribed by RNA polymerase III [56]. Our results indicate a TR
binding site in the first intron of this gene and that the expression
of GTF3c1 is upregulated in the cerebellum of hypothyroid
animals with TH replacement (Figure 5). However, the reduced
expression was found in hypothyroid animals induced by PTU,
but not in animals induced by MMI/perchlorate. This suggests
that factors other than TH may prevent the reduction in GTF3c1
expression. A recent study examining hepatic genome-wide
expression in wild type and TR knock-out mice treated with TH
or goitrogen found that, like GTF3c1, roughly half of all genes that
showed positive regulation by TH excess, exhibited no response to
TH deficiency [57]. Although that study did not attempt to
determine the presence of genomic TR binding sites that could
potentially regulate the expression of these genes, the results
suggest that the pattern of response of GTF3c1 expression in the
Figure 4. Confirmation of enriched genes identified using
ChIP-on-chip with 13 randomly selected genes by PCR in
independently prepared amplified IgG-IP, TRb-IP and TI DNAs
pool of 2 samples.
doi:10.1371/journal.pone.0004610.g004
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TH regulated genes.
MAGis a quantitatively minor component of isolated myelin that
functions in glia-axon interactions[58].The abnormalexpressionof
MAG in hypo/hyperthyroidism has previously been reported in
several studies [59–61], but there is little information on how its
expression is directly affected by TH. The current study shows that
TRb binds in the region between 2280 to 2390 bp, which
significantly influences the transcription activity. A search using an
internet based tool to identify TREs based on classical descriptions
(TESS: Transcription Element Search System [62] : located at
http://www.cbil.upenn.edu/cgi-bin/tess/tess; ) failed to identify
any of the classic TRE forms (DR4, DR6, palindromic form or
inverted palindrome), suggesting that the sequence of the binding
site is novel. We found a half TRE (AGGTCA) in this region, but
alteration of this sequence to AGATCA by site-directed mutagen-
esis had no effect on the transcriptional activity in vitro (data not
shown). This suggests that TRb may not bind to the half TRE and
that this specific sequence has no functional significance. The
expression of MAG in our animal models is correlated with TH
level suggesting that the presence of a TR binding site in the
regulatory region of the gene is genuine. Further analyses will be
needed to characterize the nature and sequence of the TR
regulatory element in this gene, but current findings indicate that
not all TREs will conform to variations of the classic forms.
In conclusion, we have identified TR binding sites associated
with 91 genes in the developing mouse cerebellum. Binding sites
may be located in different genomic contexts (both upstream and
downstream of genes, and in introns) and may not adhere to
conventional sequence models. As TR binding suggests the
presence of consensus thyroid regulatory elements and, hence,
direct TH regulation of these genes, the current study provides
support for the role of products of these genes in thyroid hormone-
directed neurodevelopment.
Figure 5. The expression of novel thyroid responsive genes in hypothyroid or hyperthyroid mouse models. A. MMI/perchlorate
induced hypothyroid, hyperthyroid or hypothyroid/replacement animal models. B. PTU induced hypothyroid animal models. RT-PCR was performed
with RNA extracted from cerebellum on PND15 (n=5). * Significantly different from control (p,0.05).
doi:10.1371/journal.pone.0004610.g005
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Animals and tissues collection
ChIP-on-chip. All animal handling procedures adhered to the
Canadian Council on Animal Care guidelines and were approved by
the Health Canada Animal Care Committee prior to the initiation of
the study. Nulliparous, sexually mature C57BL/6 mice were
purchased from Charles River (St. Constant, QC, Canada) and
were housed individually (males) or in pairs (females) in hanging
polycarbonate cages under a 12:12 hrs light-dark cycle at 23uCw i t h
food (Purina rodent chow 5010; Ralston-Purina, MO) and water
available ad libitum. After 2 weeks acclimation to the facility, breeding
was initiated by transferring 2 females to each male cage. Females
were examined within 1 hr of light cycle for the presence of a vaginal
plug as an indication of pregnancy. Plug positive females were
weighed and transferred to separate cages, where they were housed
singly and weighed 10 days post coitus to confirm pregnancy. Dams
wereallowedtolitternaturally(dayofbirth=PND1)andnumbersof
pups per litter were not adjusted. On PND 15, pups were sacrificed
by decapitation and cerebellum was removed, immediately frozen in
liquid nitrogen and stored at 280uC.
PTU hypothyroid model. Pregnant C57BL/6 mice were
supplied ad libitum with water containing diet cherry Kool-aid
(Kraft Inc., ON, Canada) with or without 0.1% PTU (Sigma-
Aldrich, Oakville, ON, Canada) from gestation day 13 to PND 15.
On PND 15, 5 male pups from different litters were sacrificed by
decapitation and cerebellum was collected and stored at 280uC.
At least one littermate of the same sex was exsanguinated under
isofluorane anaesthesia and serum retained for T4 analysis.
MMI hypo/hyperthyroid models. Twenty eight pregnant
C57BL/6 mice were divided randomly into 4 groups: control,
hypothyroid, hypothyroid/replacement and hyperthyroid. On
PND 5 all dams were supplied with drinking water containing
sucrose starting at 1% and increasing to 2% on PND 9. Dams and
their litters in the hypothyroid and hypothyroid/replacement
groups were rendered hypothyroid for 3 days by providing
drinking water containing 0.05% MMI, 1% sodium perchlorate
and 2% sucrose water starting on PND 12. On PND 15 all pups
received i.p. injections of saline containing 2 mM NaOH (Control
and hypothyroid); T4/T3 at 50 mg/5.0 mg/100 g B.W.
(hyperthyroid); or T4/T3 at 25 mg/2.5 mg/100 g B.W.
(hypothyroid/replacement). Pups were sacrificed by decapitation
exactly 4 hrs post injection. Serum was collected from trunk blood
and retained for T4 analysis. The cerebellum was rapidly
dissected, frozen in liquid nitrogen and stored at 280uC.
Chromatin immunoprecipitation (ChIP) and DNA
microarrays (chip)
ChIP was performed using EZ ChIP kits (Millipore Corpora-
tion, Danvers, MA) according to the manufacturer’s instructions.
Briefly, cerebellum from PND 15 mouse was homogenized, with a
hand-held homogenizer, in PBS containing broad-spectrum
protease inhibitors and was then cross-linked with 1% formalde-
hyde. Nuclei were collected by adding lysis buffer after cross-
linkage was stopped with glycine. To ensure that DNA fragments
ranged from 300 to 600 bp, the nuclear solution was sonicated,
using a Fisher 60 Sonic Dismembranator (Thermo Fisher
Scientific, Nepean, ON, Canada), in an ice bath with 5630 sec
bursts at 12% power, each separated by 30 sec periods. Six
percent (about 100 ml) of the sonicated solution was store at
220uC as TI, while the remainder was incubated with anti-TRb
polyclonal antibody (PA1-213, cloneTRb-62, Affinity Bioreagents,
Golden, CO) overnight with agitation at 4uC (for ChIP-PCR, half
of the remainder was incubated with anti-TRb polyclonal
antibody, the other half was incubated with normal rabbit IgG
(Millipore Corporation, Danvers, MA)). Antibody-bound chroma-
tin was precipitated with protein G conjugated agarose beads,
washed with gradient stringent buffers, and eluted with elution
buffer as per the manufacturer’s instructions. The eluted solution,
as well as the stored TI, was incubated at 65uC overnight to
reverse cross-links. IP DNA and TI DNA were then purified by
treatment with RNase, proteinase K and multiple phenol:
chloroform: isoamyl alcohol (25:24:1) extractions. Equivalent
amounts of IP DNA and TI DNA were amplified in parallel,
using a random primer method with GenomePlex Complete
Whole Genome Amplification Kit (Sigma-Aldrich, Oakville, ON,
Canada), according to the manufacturer’s instructions (15 cycles).
Genomic regions enriched by ChIP were identified using
Agilent custom microarrays (Agilent Technologies, Mississauga,
ON, Canada) containing representative sequences from 5000
mouse genes selected as potential TH-regulated candidates based
on our previous studies [19,63] or from the literatures. The full list
of genes is available upon request. The microarrays were prepared
such that each array was composed of two slides of 44,000 spots
each. Promoter oligo probes (50–60 mers) complementary to
genomic sequences ranged from 28 kb upstream to 2 kb
downstream of the TSS of each gene with 200 bp between
adjacent probes.
Amplified IP or TI DNA samples (2 mg) was labelled with Cy5-
dUTP or Cy3-dUTP (Perkin Elmer Life Sciences, Woodbridge,
ON, Canada), respectively, using CGH kits (Invitrogen, Burling-
ton, ON, Canada). Labelled DNAs (5 mg each) were hybridized
with custom promoter microarrays for 40 hrs at 65uC, then
washed and dried according to the manufacturer’s instructions.
Hybridization images were obtained using an Agilent DNA
microarray scanner and intensity data was extracted using Feature
Extraction software (Agilent Technologies). Genomic regions
enriched by ChIP were identified with a peak detection algorithm
using Chip Analytics 1.3 software, according to the manufacturer’s
instructions (Agilent Technologies). Intensity data were normal-
ized with blank subtraction followed by intra-array Lowess
normalization, while the Whitehead Error Model v1.0 was used
to calculate confidence values for each spot on each array. The
Whitehead per-array neighbourhood model v1.0 was used to
identify the bound regions. Criteria for identification of a positive
probe were: 1) P-value for probe sets (probe and its two immediate
neighbours) was less than 0.001; and 2) two of three probes in a
probe set had a single probe P-value less than 0.005, or, the center
probe in the probe set had a single probe P-value less than 0.001
and one of the flanking probes had a single P-value less than 0.1.
ChIP-PCR. Primers targeting the enriched regions identified
with ChIP-on-chip analysis were designed using BeaconDesigner
Figure 6. The transcriptional activity of the MAG promoter examined with the luciferase reporter assay. A. The location of the 3
truncated fragments used to build the reporter constructs. The PCR-confirmed ChIP enriched fragment is indicated by the black bar. The TSS and
direction is indicated with an arrow. B and C. Transcriptional activity of GH reporter construct or MAG promoter reporter constructs induced by TH.
The reporter constructs and empty vector were co-transfected into GH3 cells with pRL-TK (as a transfection efficiency control). T3 (10
28 M) was added
after 24 hrs. Firefly luciferase expression was normalized to renilla luciferase from the pRL-TK plasmid. Values are mean6S.E. (n=3). *indicates
p,0.05.
doi:10.1371/journal.pone.0004610.g006
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performed using AmpliTaq (Perkin Elmer) with amplified TRb-
IP, IgG-IP or TI DNA pooled of 2 independent samples as
templates. Primer sequences are indicated in Table S2.
Expression RT-PCR. Total RNA was extracted from
cerebellum using Trizol, and reverse transcribed into cDNA
using SuperScript III (Invitrogen). Quantitative PCR was
performed with an iCycler IQ real-time detection system (Bio-
Rad Laboratories, Mississauga, ON, Canada) using SYBR-Green.
Primers were designed using Beacon Designer 2.0, and sequences
can be found in Table S3. Gene expression levels were normalized
to Hprt, which was found to be stable using the DNA microarray
(data not shown). PCR efficiency was examined using the standard
curve for each gene. The primer specificity was determined by the
melting curve for each amplicon.
Reporter plasmid construction. Mouse MAG luciferase
reporter plasmids 1–3 were constructed by cloning PCR-derived
fragments (MAG nucleotides +14 to 2180,2280,2390) into the
luciferase vector, PGL4.10 (Promega, Madisson, WI. USA). PCRs
were performed using primers containing XhoI and BglII sites with
mouse genomic DNA as template. PCR fragments were then
subcloned into XhoI/BglII sites of pGL4.10 and the constructed
sequences were confirmed by restriction enzyme mapping and
sequencing.
Cell culture, transfection, and reporter assay. Twenty-
four hrs before transfection, GH3 cells (2610
5) were seeded in
each well of 6-well plates with F12 medium containing 10%
dextran-coated charcoal-treated FBS. Each luciferase reporter
plasmid construct (1.02 mg) was co-transfected with 0.03 mgo f
pRL-TK (Promega) into GH3 cells using 3 ml of FUGENE 6
(Agilent). Twenty four hrs post-transfection, T3 was added to a
final concentration of 10
28 M. Cells were harvested 24 hrs after
T3 addition, and then firefly and renilla luciferase activities were
determined in cell lysates using a Veritas luminometer with the
Dual-luciferase reporter assay system (Promega). Firefly luciferase
activity was normalized to renilla luciferase activity to correct for
transfection efficiency and the reporter gene expression presented
as relative luciferase units (RLU). Each incubation was performed
in duplicate and experiments were repeated 3 times.
Western blots. Lysis buffer (200 ml) was added to 1610
6
GH3 cells and 50 mg protein was loaded in each lane and
separated on a 10% SDS-PAGE gels, then were transferred to
nitrocellulose membranes at 100 V for 1 hr. Membranes were
probed with anti-TRb polyclonal antibody (Affinity Bioreagents;
3 mg/ml) overnight and HRP-conjugated goat anti-rabbit
secondary antibody (Santa Cruz Biotechnology, CA; 1:1000) for
2 hrs. Signals were detected using an ECL Plus kit (GE Healthcare
Bio-Science Inc. Baie d’Urfe, QC, Canada).
Statistical analysis. RT-PCR gene expression and luciferase
activity data are expressed as mean6S.E. Significant differences
compared to control were determined using a 2-tailed Student’s t-
test and were deemed significant if P,0.05.
Supporting Information
Table S1 ChIP PCR primers
Found at: doi:10.1371/journal.pone.0004610.s001 (0.03 MB
DOC)
Table S2 Gene expression PCR primers
Found at: doi:10.1371/journal.pone.0004610.s002 (0.03 MB
DOC)
Table S3 Serum T4 of mouse pups from in vivo TH modulation
studies
Found at: doi:10.1371/journal.pone.0004610.s003 (0.03 MB
DOC)
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